These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24689522)

  • 1. Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.
    Kumari VA; Gupta P; Srivastava MV; Kumar L; Kriplani A; Bhatla N
    J Obstet Gynaecol Res; 2014 May; 40(5):1463-5. PubMed ID: 24689522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma.
    Negishi Y; Sakai K; Noguchi Y; Iwasaki N; Kawai N
    J Obstet Gynaecol Res; 2014 Feb; 40(2):614-7. PubMed ID: 24148073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic cerebellar degeneration as the first evidence of cancer: a case report.
    Liu S; Tunkel R; Lachmann E; Nagler W
    Arch Phys Med Rehabil; 2000 Jun; 81(6):834-6. PubMed ID: 10857534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
    Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
    Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial carcinoma first presenting as paraneoplastic cerebellar degeneration.
    Erez Y; Rojansky N; Shveiky D; Ben-Meir A; Benshushan A
    Gynecol Oncol; 2007 Jun; 105(3):826-7. PubMed ID: 17428523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation.
    Bradley WH; Dottino PR; Rahaman J
    Int J Gynecol Cancer; 2008; 18(6):1364-7. PubMed ID: 18217973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic cerebellar degeneration as the first manifestation of cancer.
    Lin JT; Lachmann E; Nagler W
    J Womens Health Gend Based Med; 2001 Jun; 10(5):495-502. PubMed ID: 11445049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration.
    Forgy AP; Ewing TL; Flaningam J
    Gynecol Oncol; 2001 Jan; 80(1):96-8. PubMed ID: 11136578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer: PCD and brain metastases.
    Stepanić V; Matković V; Corusić A; Barisić D; Buković D; Ilić-Forko J
    Coll Antropol; 2007 Jun; 31(2):633-6. PubMed ID: 17847951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: Case report.
    Abdulaziz ATA; Yu XQ; Zhang L; Jiang XY; Zhou D; Li JM
    Medicine (Baltimore); 2018 Jun; 97(24):e10717. PubMed ID: 29901574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.
    Saeed DB; Gupta L
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Yo positive and late-onset paraneoplastic cerebellar degeneration associated with ovarian carcinoma: A case report.
    Cui D; Xu L; Li WY; Qian WD
    Medicine (Baltimore); 2017 Aug; 96(32):e7362. PubMed ID: 28796031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
    Lehner MJ; Gheeya JS; Siddiqui BA; Tummala S
    J Neurooncol; 2021 Jul; 153(3):441-446. PubMed ID: 34076832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
    Key RG; Root JC
    Psychooncology; 2013 Sep; 22(9):2152-5. PubMed ID: 23585287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic cerebellar degeneration mimicking development of secondary progressive multiple sclerosis in a patient with relapsing-remitting multiple sclerosis.
    Gracien R; Kordulla M; Ziemann U
    Mult Scler; 2011 Apr; 17(4):498-500. PubMed ID: 21148018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of slowly progressive anti-Yo-associated paraneoplastic cerebellar degeneration successfully treated with antitumor and immunotherapy].
    Tsuboguchi S; Yajima R; Higuchi Y; Ishikawa M; Kawachi I; Koyama Y; Nishizawa M
    Rinsho Shinkeigaku; 2016 Jul; 56(7):477-80. PubMed ID: 27356731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review.
    Le May M; Dent S
    Curr Oncol; 2018 Dec; 25(6):e585-e591. PubMed ID: 30607127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.